Drawing for ROSALINE

USPTO serial 98146062

ROSALINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SHEN, DANIEL HOWE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ROSALINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn Yoches

Kathryn Yoches LEGALFORCE RAPC WORLDWIDE, P.C.446 E SOUTHERN AVETEMPE, AZ 85282United States

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics and cosmetic preparations; Sun-tanning preparations; Cosmetic preparations for skin care; Non-medicated skin care preparationsACTIVE—
005Medicinal creams for skin care; Vitamin supplements; Dietary and nutritional supplements; Herbal supplements for boosting energy and for sexual dysfunction; Pharmaceutical preparations for increasing sexual activityACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 1, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 1, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Jun 9, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 5, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 5, 2025NREVNOTICE OF REVIVAL - E-MAILED—
May 5, 2025PETGPETITION TO REVIVE-GRANTED—
May 5, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Mar 3, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 29, 2025EXT1SOU EXTENSION 1 FILED—
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2024DOCKASSIGNED TO EXAMINER—
Sep 22, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance